Introduction
Apoptosis is used as a defense strategy for the elimination of virus-, bacteria-, and parasite-infected cells by the immune system, as well as in cell selection during the development and maintenance of tissue homeostasis (Vaux et al., 1994) . Pathogen-infected apoptotic cells are recognized and phagocytosed by macrophages, and the pathogen is eliminated, together with host cells, in an immunologically silent manner (Ren and Savill, 1998) . In contrast, pathogens have been found to antagonize apoptotic death of invaded host cells, prolonging their survival and allowing them more time to replicate (Moss et al., 1999) . Typically, viruses inhibit host cell apoptosis through the expression of anti-apoptotic genes, such as viral FLIP (v-FLIP) in herpesvirus, p35 in baculovirus, E1B 19K in adenovirus, and CrmA in cow pox virus (Benedict et al., 2002) . Little is known, however, regarding the molecule(s) through which intracellular parasites interfere with host cell apoptosis (Heussler et al., 2001; James and Green, 2004) .
Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease in Latin America (Morel and Lazdins, 2003) , occurs as two forms in mammalian hosts. The non-dividing trypomastigote form circulates in the bloodstream and invades a wide variety of nucleated cells, preferably heart muscle cells. Once in the host cell cytoplasm, the parasite transforms into the amastigote form. The intracellular parasite multiplies by binary fission, kills the host cell, and returns to the circulation as trypomastigotes that propagate the infection (Brener, 1973) . CD8 + T lymphocytes are involved in T. cruzi infection, killing infected cells by triggering their death through the interaction of Fas ligand with its receptor and of tumor necrosis factor (TNF)-α with its receptor, TNFR (Tarleton et al., 1992; Rottenberg et al., 1993; Locksley et al., 2001) . T. cruzi, however, can persist for many years in the mammalian host as intracellular amastigotes,
suggesting that the parasite antagonizes apoptotic death of the invaded host cells. Chagas' 3 disease is characterized by two distinct phases (Brener, 1973) . The acute phase, which lasts 2 to 4 months, involves a number of parasites detected in the blood stream as well as in host tissues, followed by a life-long chronic phase in up to 30% of the patients. In chronic phase of Chagas' disease, T. cruzi persists in human with a nearly undetectable parasite load, and then the ultimate cause of the disease has been still hotly debated. However, currently accumulating evidence indicates that inefficient immune response to the parasites results in increased parasite load and increased incidence of chronic phase of Chagas' disease, and that intracellular persistence of the parasites is an aggravating cause of even chronic phase of Chagas' disease (Tarleton and Zhang, 1999; Higuchi Mde et al., 2003) . Therefore, how T. cruzi persists in host cell is one of the most important studies to understand the pathogenicity.
Upon binding of the trimeric Fas ligands or agonistic antibodies, Fas receptors recruit adaptor molecules (FADD) and procaspase-8 to form the death-inducing signaling complex (DISC). In this complex, procaspase-8 is activated to caspase-8, triggering the proteolytic cascade of effecter caspases leading to cell death . We previously demonstrated that induction of Fas-and TNFR-mediated apoptosis was more strongly inhibited in T. cruzi-infected cells than in uninfected cells, and that caspase-8 activity could not be measured upon Fas stimulation of T. cruzi-infected cells (Nakajima-Shimada et al., 2000) . We also showed that X-ray, H 2 O 2 , cholchicin, and etoposide, respectively, induced an essentially same degree of apoptosis between T. cruzi-infected and uninfected cells. These findings indicate that parasite infection inhibits one of the earliest steps of death receptor-mediated apoptosis.
Here we report that T. cruzi uses the host's cellular FLICE inhibitory protein (c-FLIP), the only known inhibitor specific for death receptor-mediated apoptosis in mammals (Thome and Tschopp, 2001) , for the inhibition of Fas-mediated apoptosis by post-transcriptional 4 upregulation. This finding indicates that T. cruzi modulates and exploits a host molecule to counteract death receptor signaling, a finding consistent with the view that parasites hijack the host cell, placing themselves in the driver's seat (Beverley, 1996) .
Materials and Methods
Cells and parasites. HT1080 cells, a human fibrosarcoma cell line obtained from Japan Health
Sciences Foundation (Tokyo, Japan), were cultured in Dulbecco's modified Eagle's medium (DMEM; Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% fetal bovine serum.
HT1080 cells (2×10 5 ) were infected with 4×10 5 T. cruzi trypomastigotes (Tulahuen strain) and cultured for 4 days. A cell population with an infection rate greater than 80% was considered as infected cells. The infection complex of HT1080 cells and T. cruzi was maintained as described (Nakajima-Shimada et al., 2000) .
Antibodies. Rabbit anti-c-FLIP polyclonal antibodies specific for amino acid residues 2 to 17 was obtained from Upstate Biotechnology (Lake Placid, NY Northern blotting. Total RNA was isolated using TRIzol (Life Technologies, Tokyo, Japan)
according to the manufacturer's instruction. Total RNA was size-fractionated and blotting was performed using the VacuGene XL protocol (Amersham Biosciences, Piscataway, NJ). The c-FLIP probe was DIG-labeled using PCR Probe Synthesis Kit (Roche, Mannheim, Germany) in the presence of 5'-GAGTTGGAGAAACTAAAT-3' and 5'-ACACTCTGGGAGCCTCCT-3', the forward and reverse primers, respectively.
Immunohistochemistry. Five-week-old female BALB/c mice (Japan SLC, Hamamatsu, Japan)
were intraperitoneally infected with T. cruzi trypomastigotes (5,000 parasites/mouse) recovered from the preceding infected mice. Fourteen days later, heart samples were collected and frozen in blocks of optimal cutting temperature compound (OTC, Sakura, Tokyo, Japan) in liquid nitrogen according to standard procedure. The OTC block was cut in 4 μm sections onto silane-coated slide glasses. The sections were incubated with 10% normal goat blocking serum, and then with anti-c-FLIP monoclonal antibody G-11 (Santa Cruz Biotechnology, Santa Cruz, CA) diluted to 1:100. After washing with PBS, the sections were incubated with secondary antibody (horse Immunoprecipitation. Immunoprecipitation was performed using magnetic beads as described by the manufacturer (New England Biolabs, Beverly, MA). Cells were lysed with IP buffer (150 mM NaCl, 10 mM Tris at pH 7.4, 1 mM EDTA, 1 mM EGTA at pH 8.0, 0.2 mM sodium orthovanadate, 0.2 mM PMSF, 1% Triton X-100, and 0.5% Nonidet P-40). The crude cell extract was pre-incubated with Protein G Magnetic Beads (New England Biolabs) and the resulting supernatant was incubated with the indicated antibody and the beads. Magnetic beads were washed with IP buffer and suspended in SDS sample loading buffer. After incubation at 70 o C for 5 min, each sample was subjected to SDS-PAGE and Western blotting as described above.
DISC analysis was performed using a standard method (Krueger et al., 2001) . Briefly, cells (1×10 7 ) were trypsinized, collected by centrifugation, and then resuspended in 5 ml of 7 DMEM. Fas receptor was stimulated with 2 μg/ml of anti-Fas monoclonal antibody (APO1-3)
for 20 min. Cells were washed with ice cold PBS and lysed in 1 ml of lysis buffer (30 mM Tris at pH 7.5, 150 mM NaCl, 1 mM PMSF, 1% Triton X-100 and 10% glycerol) for 30 min at 4ºC.
Protein A-Sepharose beads (Amersham Bioscience) was added to the lysate. As a negative control, APO1-3 and protein A-Sepharose beads were added to the lysate of unstimulated cells.
Sample and negative control lysates were incubated at 4ºC on a rotator for 3 h. The beads were washed four times in lysis buffer and suspended and boiled in SDS sample loading buffer, and then each sample was subjected to SDS-PAGE and Western blotting as described above.
siRNA experiment. For depletion of c-FLIP, we used siRNA generated in vitro by RNase III from Escherichia coli (Yang et al., 2002) . To produce the long double-stranded RNA (dsRNA), c-FLIP gene (nucleotides 89-698 downstream from the start codon) were amplified by PCR using the specific primers 5'-GCGTAATACGACTCACTATAGGGAGAAGATGTGGTTCCACCTAATG-3' (forward) and 5'-GCGTAATACGACTCACTATAGGGAGAGCTTCTGATTCCTGAATGGA-3' (reverse), which also contain a T7 promoter and a leader sequence. Double-stranded (ds) RNA was generated using TurboScript T7 Transcription Kit (Gene Therapy Systems, San Diego, CA). The dsRNA was converted to siRNA using ShortCut RNase III (New England Biolabs). The siRNAs were precipitated in ethanol and then dissolved in nuclease-free water. The concentration of the siRNAs was determined spectrophotometrically and by ethidium bromide staining in 3% agarose gels. As a negative control, we used luciferase siRNA (Luciferase GL2, Fasmac, Kanagawa, Japan).
Transfection of siRNAs (200 ng/ml) into 40-50% confluent HT1080 cells cultured in 8 wells of a 12-well plate was performed using Lipofectamine 2000 (Invitrogen) in accordance with the manufacturer's instruction. After cultivation for 24-30 h, the cells were infected with 2×10 6 trypomastigotes as previously described (Nakajima-Shimada et al., 2000) , incubated for 24 h further, and harvested for Western blotting or apoptosis induction followed by cell death assay.
Results

T. cruzi infection upregulates c-FLIP L protein expression
Since our previous study has demonstrated that caspase-8 activity could not be measured 
Post-transcriptional upregulation of c-FLIP protein in T. cruzi-infected cells
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We examined whether the increase in c-FLIP L protein was due to the elevation of the corresponding mRNA in T. cruzi-infected cells. Northern blots showed that T. cruzi-infected cells had a level of c-FLIP mRNA (2.1 kb) nearly equivalent to that in uninfected cells ( Figure   2A ). In infected cells, mRNA of about 1 kb was slightly upregulated, but we did not elucidate whether this mRNA was translated. Importantly, c-FLIP L mRNA level does not parallel the increased protein level (see Figure 1 ).
Since c-FLIP is a short-lived protein, inhibitors of protein synthesis lower its expression level in a variety of cell lines (Imanishi et al., 2000a) . In contrast to uninfected cells, T. 
c-FLIP is also upregulated in T. cruzi-infected cardiomyocytes in vivo
We also examined whether c-FLIP protein is increased in T. cruzi-infected mouse heart muscle cells, in which Chagasic myocarditis and amastigotes are often observed ( Figure 3A) . The monoclonal anti-c-FLIP antibody (G-11), with specificity for c-FLIP in immunohistochemical analysis (Kim and Seong, 2003; Mathas et al., 2004) , revealed strong staining throughout the cytoplasm of an amastigote-dwelling cardiomyocyte, with obscure staining in uninfected cells.
The fluorescence intensity of fifty-eight each of T. cruzi-infected and uninfected cells was measured for statistical evaluation ( Figure 3B ). Upregulation of c-FLIP was observed in all T.
cruzi-infected cells, showing the fluorescence intensity significantly (p<0.01) higher in the infected than in the uninfected cells. These results indicate that c-FLIP is also upregulated in T.
cruzi-infected cells in vivo when compared with uninfected cells.
The fluorescence intensity of the infected cardiomyocytes in vivo did not clearly parallel in vitro studies (see Figure 1A) , probably because of the lightly and heavily infected host cells in vivo and in vitro, respectively, with average parasite numbers of 5.5 and 15-20 per infected cell.
Additionally, the T. cruzi-infected heart muscle cell, cut into a thin section, may exhibit a partial fluorescence staining of the whole cell. These results are consistent with a suggestion that the degree of the fluorescence intensity in host cells in vivo is lower than that of Western blot in vitro.
Signals were also detected near the cells lacking the parasite infection in the section shown in Fig. 3A . Importantly, since these cells are not stained throughout the cytoplasm, the fluorescence would not be c-FLIP signal. We experienced that the mouse blood vessel was non-specifically stained with anti-c-FLIP antibody (G-11). Therefore, it may be possible that blood vessels near uninfected cells were non-specifically detected with this antibody.
Alternatively, it may be possible that, since heart muscle cells are very long, a part of infected cells, whose nuclei and infected parasites were not seen, was stained with the antibody.
T. cruzi infection inhibits Fas-stimulated procaspase-8 activation by recruitment of c-FLIP L into the DISC
At the DISC, procaspase-8 is cleaved and converted to p43/41 fragments, and these are further processed to active caspase-8, a heterotetramer composed of two p18 and two p10 polypeptides . In the presence of a large amount of c-FLIP L , procaspase-8 and c-FLIP L are recruited into the DISC, the p43/41 cleavage products of caspase-8 and p43 cleavage product 11 of c-FLIP L are generated, and then the cleavage intermediates remain bound to the DISC and can no longer be replaced by procaspase-8 (Scaffidi et al., 1999; Krueger et al., 2001) . Since c-FLIP L protein is highly expressed in T. cruzi-infected cells, we examined procaspase-8 processing in infected and control cells following Fas stimulation (Figures 4A and B) . Some tumor cells highly express c-FLIP and its level has correlated with cellular resistance to death receptor-mediated apoptosis (Igney and Krammer, 2002) . Using siRNA specific for c-FLIP, it was recently shown that this protein is a key molecule in death receptor 14 resistance in Hodgkin/Reed-Sternberg cells (Mathas et al., 2004) . However, c-FLIP expression is reportedly regulated by transcriptional mechanism for most of these cells. By contrast, T. cruzi post-transcriptionally stabilizes the host c-FLIP protein (see Figure 2B ), a unique strategy that the parasite takes advantage of the short-lived nature of the target protein.
T. cruzi infection has been shown to protect mammalian cells from apoptotic death caused by growth factor deprivation (Clark and Kuhn, 1999; Chuenkova and Pereira, 2000; Chuenkova et al., 2001 ). This phenomenon, however, has not been investigated from the viewpoint of inhibition of death receptor-mediated apoptosis. Interestingly, T. cruzi trans-sialidase activates phosphatidylinositol 3-kinase (PI3K)/Akt protein kinase signaling, which is utilized as a survival pathway in a variety of cell types (Chuenkova et al., 2001) . Additionally, c-FLIP expression depends on the PI3K/Akt protein kinase activity in many cell lines, where its upregulation may take place at a transcriptional level (Panka et al., 2001) . By contrast, our data clearly show that c-FLIP, at least c-FLIP L , is upregulated post-transcriptionally in T. cruzi-infected cells, implying that its upregulation is independent on PI3K/Akt protein kinase signaling. Indeed, treatment of T.
cruzi-infected cells with LY294002, a specific and permeable PI3K inhibitor, at 50 μM for 24 h did not affect c-FLIP expression or sensitivity to Fas stimulation (our unpublished data).
How T. cruzi selectively inhibits the degradation of c-FLIP protein is an important issue.
As a short-lived protein, c-FLIP level would be regulated by the ubiquitin-proteasome pathway, in which the specific ubiquitin ligase (E3) is involved. In general, however, identification of physiologically functional E3 is important, but difficult, in that the endogenous expression level of c-FLIP is very low (Scaffidi et al., 1999) , and in that c-FLIP interact with various key proteins, including procaspase-8, FADD, tumor necrosis factor receptor-associated factors 1 and 2, and
Rip and Raf kinases (Kataoka et al., 2000) . Due to these factors, it would therefore be difficult to 15 pinpoint the role of the E3 associated with the post-transcriptional upregulation of c-FLIP.
Nevertheless, we believe that further molecular and cellular pursuit of insight into how T. cruzi stabilizes c-FLIP contributes to identify the specific E3.
While we found that c-FLIP was highly expressed in infected cardiomyocytes in vivo, it is not clear that the protein is the only molecule that inhibits death receptor-mediated apoptosis in vivo. Since c-FLIP knock-out mice do not survive past day 10.5 of embryogenesis (Yeh et al., 2000) , the role of c-FLIP in adult mammals is not well understood. However, it has been shown that c-FLIP is highly expressed in the adult human and murine heart when compared with other organs, and suggested that down regulation of c-FLIP sensitized cardiac myocytes to apoptotic death (Rasper et al., 1998) . Furthermore, c-FLIP is abundant in normal cardiomyocytes from failing human hearts, but the protein is absent from apoptotic cardiac myocytes (Imanishi et al., 2000b) . It is, therefore, strongly suggested that c-FLIP functions as a strong anti-apoptotic factor in T. cruzi-dwelling cardiomyocytes in hearts from infected animals. Since the differences in biological features of T. cruzi amastigotes in acute and chronic phase of infection are poorly understood, whether the chronic stage amastigotes also upregulate c-FLIP is interesting.
However, these amastigotes could not be observed by standard histochemical techniques due to the very low parasite density. To address this question, we need experimental techniques that allow more exhaustive analysis of a whole mouse heart and we need more detailed information about the cell biological features of the chronic stage amastigotes (e.g., their method of replication and the spot(s) they preferably persist). On the other hand, it has been proposed that inadequate clearance of the acute phase parasites due to a substandard immune response leads to chronic phase of Chagas' disease. Therefore, c-FLIP may be a clue to understanding how the intracellular parasite persists in mammalian cells, eventually giving rise to pathogenicity at the 16 molecular level. 
